Home Online Features Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication
Prospective Clinical Utility Study of Lucid Diagnostics’ EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication
Press Releases
December 11, 2024

Prospective Clinical Utility Study of Lucid Diagnostics’ EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

By Lucid Diagnostics

Study demonstrates outstanding clinical utility including an exceptionally high 85% patient compliance with referral to confirmatory upper endoscopy following EsoGuard esophageal precancer testing

bradford

The Bradford Era

email
Local & Social